Circulating CD45(+)EpCAM(+) cells as a diagnostic marker for early-stage primary lung cancer

Lung cancer is a highly prevalent type of cancer, accounting for 11.6% of all cancer incidences. Early detection and treatment can significantly improve the survival rate and quality of life of patients; however, there is no accurate, effective, and easy-to-use test for early lung cancer screening....

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhen, Li, Peng, Wu, Zhaojun, Li, Bin, Li, Wenjing, Zhao, Mingming, Zhou, Xiaobin, Wang, Zeyao, Yu, Zhongjie, Liu, Wenna, Zhu, Wenshu, Wang, Haibo, Wang, Yongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487715/
https://www.ncbi.nlm.nih.gov/pubmed/36147748
http://dx.doi.org/10.3389/fmedt.2022.982308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487715/
https://www.ncbi.nlm.nih.gov/pubmed/36147748
http://dx.doi.org/10.3389/fmedt.2022.982308

Ejemplares similares